$HAE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HAEMONETICS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HAEMONETICS CORP. Get notifications about new insider transactions in HAEMONETICS CORP for free.
Page: < prev 1 ... 9 10 11 12 13 14 15 16 16 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 03 2009 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 59.44 | 5,879 | 349,448 | 5,879 | |
Aug 03 2009 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.01 | 367 | 4 | 5,722 | 5.4 K to 5.7 K (+6.85 %) |
Aug 03 2009 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | A | 59.44 | 5,879 | 349,448 | 5,879 | |
Aug 03 2009 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Grant | A | 0.01 | 367 | 4 | 2,008 | 1.6 K to 2 K (+22.36 %) |
Aug 03 2009 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 59.44 | 5,879 | 349,448 | 5,879 | |
Aug 03 2009 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 367 | 4 | 101,008 | 100.6 K to 101 K (+0.36 %) |
Jul 31 2009 | HAE | HAEMONETICS CORP | Brancazio Phillip John | VP, Global Manufact ... | Option Exercise | A | 58.64 | 11,441 | 670,900 | 11,441 | |
Jul 31 2009 | HAE | HAEMONETICS CORP | Brancazio Phillip John | VP, Global Manufact ... | Grant | A | 0.01 | 715 | 7 | 715 | 0 to 715 |
May 07 2009 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Buy | P | 43.89 | 277 | 12,156 | 6,658 | 6.4 K to 6.7 K (+4.34 %) |
May 06 2009 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 53.70 | 799 | 42,906 | 22,193 | 23 K to 22.2 K (-3.48 %) |
May 05 2009 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Donor Di ... | Buy | P | 43.89 | 308 | 13,517 | 6,616 | 6.3 K to 6.6 K (+4.88 %) |
May 05 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Buy | P | 43.89 | 347 | 15,228 | 30,264 | 29.9 K to 30.3 K (+1.16 %) |
May 05 2009 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | P | 43.89 | 152 | 6,671 | 4,660 | 4.5 K to 4.7 K (+3.37 %) |
May 05 2009 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Buy | P | 43.89 | 424 | 18,607 | 3,339 | 2.9 K to 3.3 K (+14.55 %) |
May 05 2009 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Buy | P | 43.89 | 424 | 18,607 | 15,849 | 15.4 K to 15.8 K (+2.75 %) |
May 05 2009 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | P | 43.89 | 424 | 18,607 | 22,992 | 22.6 K to 23 K (+1.88 %) |
Apr 06 2009 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | A | 55.37 | 32,845 | 1,818,628 | 32,845 | |
Apr 06 2009 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Grant | A | 0.01 | 2,053 | 21 | 22,568 | 20.5 K to 22.6 K (+10.01 %) |
Mar 19 2009 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Buy | P | 55.63 | 3,000 | 166,879 | 3,641 | 641 to 3.6 K (+468.02 %) |
Mar 06 2009 | HAE | HAEMONETICS CORP | White Jonathan | VP Research and Dev ... | Buy | P | 53.49 | 1,500 | 80,239 | 1,500 | 0 to 1.5 K |
Mar 03 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Option Exercise | M | 15.88 | 5,000 | 79,375 | 0 | |
Mar 03 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Option Exercise | M | 15.41 | 4,750 | 73,180 | 0 | |
Mar 03 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Sell | S | 51.93 | 5,000 | 259,651 | 29,917 | 34.9 K to 29.9 K (-14.32 %) |
Mar 03 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Buy | M | 15.88 | 5,000 | 79,375 | 34,917 | 29.9 K to 34.9 K (+16.71 %) |
Mar 03 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Sell | S | 51.93 | 4,750 | 246,668 | 29,917 | 34.7 K to 29.9 K (-13.70 %) |
Mar 03 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Buy | M | 15.41 | 4,750 | 73,180 | 34,667 | 29.9 K to 34.7 K (+15.88 %) |
Mar 06 2009 | HAE | HAEMONETICS CORP | White Jonathan | VP Research and Dev ... | Option Exercise | A | 60.05 | 17,641 | 1,059,342 | 17,641 | |
Mar 06 2009 | HAE | HAEMONETICS CORP | White Jonathan | VP Research and Dev ... | Grant | A | 0.01 | 1,103 | 11 | 1,103 | 0 to 1.1 K |
Feb 18 2009 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Option Exercise | M | 26.11 | 100,000 | 2,610,500 | 0 | |
Feb 18 2009 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Sell | S | 59.85 | 100,000 | 5,984,950 | 9,020 | 109 K to 9 K (-91.73 %) |
Feb 18 2009 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Buy | M | 26.11 | 100,000 | 2,610,500 | 109,020 | 9 K to 109 K (+1,108.65 %) |
Feb 05 2009 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Option Exercise | M | 41.15 | 13,000 | 534,950 | 7,000 | |
Feb 05 2009 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 62.85 | 13,000 | 817,050 | 641 | 13.6 K to 641 (-95.30 %) |
Feb 05 2009 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Buy | M | 41.15 | 13,000 | 534,950 | 13,641 | 641 to 13.6 K (+2,028.08 %) |
Feb 03 2009 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | M | 30.39 | 3,000 | 91,155 | 9,500 | |
Feb 03 2009 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 63.00 | 3,000 | 189,000 | 4,508 | 7.5 K to 4.5 K (-39.96 %) |
Feb 03 2009 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | M | 30.39 | 3,000 | 91,155 | 7,508 | 4.5 K to 7.5 K (+66.55 %) |
Jan 27 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Sell | S | 60.00 | 2,477 | 148,620 | 29,917 | 32.4 K to 29.9 K (-7.65 %) |
Jan 05 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Option Exercise | M | 18.94 | 25,000 | 473,438 | 0 | |
Jan 05 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Sell | S | 55.93 | 25,000 | 1,398,310 | 32,394 | 57.4 K to 32.4 K (-43.56 %) |
Jan 05 2009 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, Corporate Affai ... | Buy | M | 18.94 | 25,000 | 473,438 | 57,394 | 32.4 K to 57.4 K (+77.17 %) |
Dec 10 2008 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | M | 29.90 | 20,000 | 597,900 | 0 | |
Dec 10 2008 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 58.00 | 20,000 | 1,160,000 | 1,641 | 21.6 K to 1.6 K (-92.42 %) |
Dec 10 2008 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Buy | M | 29.90 | 20,000 | 597,900 | 21,641 | 1.6 K to 21.6 K (+1,218.77 %) |
Nov 06 2008 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Buy | P | 57.95 | 3,500 | 202,829 | 9,941 | 6.4 K to 9.9 K (+54.34 %) |
Nov 04 2008 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | P | 45.44 | 145 | 6,589 | 4,508 | 4.4 K to 4.5 K (+3.32 %) |
Nov 04 2008 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, General Counsel | Buy | P | 45.44 | 147 | 6,680 | 32,394 | 32.2 K to 32.4 K (+0.46 %) |
Nov 04 2008 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Buy | P | 45.44 | 213 | 9,679 | 6,381 | 6.2 K to 6.4 K (+3.45 %) |
Oct 31 2008 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Sell | S | 55.35 | 55 | 3,044 | 2,915 | 3 K to 2.9 K (-1.85 %) |
Oct 29 2008 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Chief Operating Off ... | Sell | S | 53.50 | 109 | 5,832 | 20,515 | 20.6 K to 20.5 K (-0.53 %) |
Oct 29 2008 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 53.50 | 68 | 3,638 | 4,363 | 4.4 K to 4.4 K (-1.53 %) |
Oct 29 2008 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Sell | S | 50.08 | 107 | 5,359 | 6,168 | 6.3 K to 6.2 K (-1.71 %) |
Oct 29 2008 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, General Counsel | Sell | S | 53.50 | 68 | 3,638 | 32,247 | 32.3 K to 32.2 K (-0.21 %) |
Oct 27 2008 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Option Exercise | A | 52.63 | 49,020 | 2,579,923 | 49,020 | |
Oct 27 2008 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Grant | A | 0.01 | 3,064 | 31 | 6,275 | 3.2 K to 6.3 K (+95.42 %) |
Oct 24 2008 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | A | 54.55 | 3,603 | 196,544 | 3,603 | |
Oct 24 2008 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Grant | A | 0.01 | 900 | 9 | 4,431 | 3.5 K to 4.4 K (+25.49 %) |
Oct 24 2008 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, General Counsel | Option Exercise | A | 54.55 | 14,294 | 779,738 | 14,294 | |
Oct 24 2008 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, General Counsel | Grant | A | 0.01 | 893 | 9 | 32,315 | 31.4 K to 32.3 K (+2.84 %) |
Oct 24 2008 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Option Exercise | A | 54.55 | 21,441 | 1,169,607 | 21,441 | |
Oct 24 2008 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Grant | A | 0.01 | 1,340 | 13 | 3,211 | 1.9 K to 3.2 K (+71.62 %) |
Oct 24 2008 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Option Exercise | A | 54.55 | 11,911 | 649,745 | 11,911 | |
Oct 24 2008 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Grant | A | 0.01 | 744 | 7 | 2,970 | 2.2 K to 3 K (+33.42 %) |
Oct 24 2008 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Chief Operating Off ... | Option Exercise | A | 54.55 | 28,588 | 1,559,475 | 28,588 | |
Oct 24 2008 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Chief Operating Off ... | Grant | A | 0.01 | 1,786 | 18 | 20,624 | 18.8 K to 20.6 K (+9.48 %) |
Oct 24 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Option Exercise | A | 54.55 | 64,324 | 3,508,874 | 64,324 | |
Oct 24 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Grant | A | 0.01 | 4,020 | 40 | 9,020 | 5 K to 9 K (+80.40 %) |
Oct 17 2008 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, General Counsel | Gift | G | 0.00 | 5,000 | 0 | 31,422 | 36.4 K to 31.4 K (-13.73 %) |
Oct 16 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Option Exercise | M | 21.91 | 50,000 | 1,095,500 | 0 | |
Oct 16 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Sell | S | 56.33 | 50,000 | 2,816,405 | 5,000 | 55 K to 5 K (-90.91 %) |
Oct 16 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Buy | M | 21.91 | 50,000 | 1,095,500 | 55,000 | 5 K to 55 K (+1,000.00 %) |
Sep 10 2008 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Option Exercise | M | 22.91 | 2,748 | 62,947 | 6,033 | |
Sep 10 2008 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Option Exercise | M | 15.88 | 18,904 | 300,101 | 0 | |
Sep 10 2008 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Sell | S | 65.00 | 2,748 | 178,620 | 15,425 | 18.2 K to 15.4 K (-15.12 %) |
Sep 10 2008 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Buy | M | 22.91 | 2,748 | 62,947 | 18,173 | 15.4 K to 18.2 K (+17.82 %) |
Sep 10 2008 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Sell | S | 65.00 | 18,904 | 1,228,760 | 15,425 | 34.3 K to 15.4 K (-55.07 %) |
Sep 10 2008 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Buy | M | 15.88 | 18,904 | 300,101 | 34,329 | 15.4 K to 34.3 K (+122.55 %) |
Sep 10 2008 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Option Exercise | M | 22.91 | 11,146 | 255,314 | 8,781 | |
Sep 10 2008 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Option Exercise | M | 15.41 | 10,500 | 161,766 | 0 | |
Sep 10 2008 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Sell | S | 65.00 | 11,146 | 724,490 | 15,425 | 26.6 K to 15.4 K (-41.95 %) |
Sep 10 2008 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Buy | M | 22.91 | 11,146 | 255,314 | 26,571 | 15.4 K to 26.6 K (+72.26 %) |
Sep 10 2008 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Sell | S | 65.00 | 10,500 | 682,500 | 15,425 | 25.9 K to 15.4 K (-40.50 %) |
Sep 10 2008 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Buy | M | 15.41 | 10,500 | 161,766 | 25,925 | 15.4 K to 25.9 K (+68.07 %) |
Sep 16 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Option Exercise | M | 21.91 | 50,000 | 1,095,500 | 50,000 | |
Sep 16 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Sell | S | 63.75 | 50,000 | 3,187,630 | 5,000 | 55 K to 5 K (-90.91 %) |
Sep 16 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Buy | M | 21.91 | 50,000 | 1,095,500 | 55,000 | 5 K to 55 K (+1,000.00 %) |
Aug 19 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Option Exercise | M | 21.91 | 50,000 | 1,095,500 | 100,000 | |
Aug 19 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Sell | S | 61.06 | 50,000 | 3,052,785 | 5,000 | 55 K to 5 K (-90.91 %) |
Aug 19 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Buy | M | 21.91 | 50,000 | 1,095,500 | 55,000 | 5 K to 55 K (+1,000.00 %) |
Aug 04 2008 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Option Exercise | A | 58.46 | 5,664 | 331,117 | 5,664 | |
Aug 04 2008 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Grant | A | 0.01 | 354 | 4 | 641 | 287 to 641 (+123.34 %) |
Aug 12 2008 | HAE | HAEMONETICS CORP | Corlin Remi | President, Asia | Option Exercise | M | 33.15 | 9,000 | 298,350 | 0 | |
Aug 12 2008 | HAE | HAEMONETICS CORP | Corlin Remi | President, Asia | Option Exercise | M | 31.66 | 5,000 | 158,300 | 0 | |
Aug 12 2008 | HAE | HAEMONETICS CORP | Corlin Remi | President, Asia | Option Exercise | M | 22.91 | 4,500 | 103,078 | 0 | |
Aug 12 2008 | HAE | HAEMONETICS CORP | Corlin Remi | President, Asia | Sell | S | 63.17 | 5,000 | 315,861 | 884 | 5.9 K to 884 (-84.98 %) |
Aug 12 2008 | HAE | HAEMONETICS CORP | Corlin Remi | President, Asia | Buy | M | 31.66 | 5,000 | 158,300 | 5,884 | 884 to 5.9 K (+565.61 %) |
Aug 12 2008 | HAE | HAEMONETICS CORP | Corlin Remi | President, Asia | Sell | S | 63.17 | 9,000 | 568,550 | 884 | 9.9 K to 884 (-91.06 %) |
Aug 12 2008 | HAE | HAEMONETICS CORP | Corlin Remi | President, Asia | Buy | M | 33.15 | 9,000 | 298,350 | 9,884 | 884 to 9.9 K (+1,018.10 %) |
Aug 12 2008 | HAE | HAEMONETICS CORP | Corlin Remi | President, Asia | Sell | S | 63.17 | 4,500 | 284,275 | 884 | 5.4 K to 884 (-83.58 %) |
Aug 12 2008 | HAE | HAEMONETICS CORP | Corlin Remi | President, Asia | Buy | M | 22.91 | 4,500 | 103,078 | 5,384 | 884 to 5.4 K (+509.05 %) |
Aug 04 2008 | HAE | HAEMONETICS CORP | MEELIA RICHARD J | Director | Option Exercise | A | 58.46 | 5,664 | 331,117 | 5,664 | |
Aug 04 2008 | HAE | HAEMONETICS CORP | MEELIA RICHARD J | Director | Grant | A | 0.01 | 354 | 4 | 641 | 287 to 641 (+123.34 %) |
Aug 04 2008 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | A | 58.46 | 5,664 | 331,117 | 5,664 | |
Aug 04 2008 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 0.01 | 354 | 4 | 641 | 287 to 641 (+123.34 %) |
Aug 04 2008 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | A | 58.46 | 5,664 | 331,117 | 5,664 | |
Aug 04 2008 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Grant | A | 0.01 | 354 | 4 | 6,441 | 6.1 K to 6.4 K (+5.82 %) |
Aug 04 2008 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 58.46 | 5,664 | 331,117 | 5,664 | |
Aug 04 2008 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.01 | 354 | 4 | 5,083 | 4.7 K to 5.1 K (+7.49 %) |
Aug 04 2008 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | A | 58.46 | 5,664 | 331,117 | 5,664 | |
Aug 04 2008 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Grant | A | 0.01 | 354 | 4 | 1,641 | 1.3 K to 1.6 K (+27.51 %) |
Aug 04 2008 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 58.46 | 5,664 | 331,117 | 5,664 | |
Aug 04 2008 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 354 | 4 | 100,641 | 100.3 K to 100.6 K (+0.35 %) |
Jul 22 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Option Exercise | M | 21.91 | 50,000 | 1,095,500 | 150,000 | |
Jul 22 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Sell | S | 55.00 | 50,000 | 2,750,000 | 5,000 | 55 K to 5 K (-90.91 %) |
Jul 22 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Buy | M | 21.91 | 50,000 | 1,095,500 | 55,000 | 5 K to 55 K (+1,000.00 %) |
Jul 01 2008 | HAE | HAEMONETICS CORP | Pare Anthony | Option Exercise | M | 26.11 | 500 | 13,053 | 3,500 | ||
Jul 01 2008 | HAE | HAEMONETICS CORP | Pare Anthony | Sell | S | 57.40 | 500 | 28,700 | 2,523 | 3 K to 2.5 K (-16.54 %) | |
Jul 01 2008 | HAE | HAEMONETICS CORP | Pare Anthony | Buy | M | 26.11 | 500 | 13,053 | 3,023 | 2.5 K to 3 K (+19.82 %) | |
May 20 2008 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Chief Operating Off ... | Sell | S | 55.44 | 775 | 42,966 | 18,838 | 19.6 K to 18.8 K (-3.95 %) |
Jun 17 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Option Exercise | M | 21.91 | 50,000 | 1,095,500 | 200,000 | |
Jun 17 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Sell | S | 57.13 | 50,000 | 2,856,330 | 5,000 | 55 K to 5 K (-90.91 %) |
Jun 17 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Buy | M | 21.91 | 50,000 | 1,095,500 | 55,000 | 5 K to 55 K (+1,000.00 %) |
May 20 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Option Exercise | M | 21.91 | 50,000 | 1,095,500 | 250,000 | |
May 20 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Sell | S | 55.05 | 50,000 | 2,752,620 | 5,000 | 55 K to 5 K (-90.91 %) |
May 20 2008 | HAE | HAEMONETICS CORP | NUTTER BRAD | President & CEO | Buy | M | 21.91 | 50,000 | 1,095,500 | 55,000 | 5 K to 55 K (+1,000.00 %) |
May 06 2008 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Buy | P | 53.59 | 1,800 | 96,462 | 6,087 | 4.3 K to 6.1 K (+41.99 %) |
May 06 2008 | HAE | HAEMONETICS CORP | BEUCLER MARK | Buy | P | 44.35 | 422 | 18,717 | 1,989 | 1.6 K to 2 K (+26.93 %) | |
May 06 2008 | HAE | HAEMONETICS CORP | Conneely Jan | VP & GM, Arryx, Inc ... | Buy | P | 44.35 | 304 | 13,483 | 1,041 | 737 to 1 K (+41.25 %) |
May 06 2008 | HAE | HAEMONETICS CORP | EBBELING ROBERT B | Vice President, Ope ... | Buy | P | 44.35 | 479 | 21,245 | 15,425 | 14.9 K to 15.4 K (+3.20 %) |
May 06 2008 | HAE | HAEMONETICS CORP | Hattori Keiko | President, Haemonet ... | Buy | P | 44.35 | 126 | 5,588 | 716 | 590 to 716 (+21.36 %) |
May 06 2008 | HAE | HAEMONETICS CORP | Granville William | VP, Manufacturing | Buy | P | 44.35 | 411 | 18,229 | 12,188 | 11.8 K to 12.2 K (+3.49 %) |
May 06 2008 | HAE | HAEMONETICS CORP | O'Shaughnessy James | Buy | P | 44.35 | 440 | 19,515 | 3,781 | 3.3 K to 3.8 K (+13.17 %) | |
May 06 2008 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President, Patient ... | Buy | P | 44.35 | 479 | 21,245 | 19,613 | 19.1 K to 19.6 K (+2.50 %) |
May 05 2008 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Buy | P | 44.35 | 479 | 21,245 | 2,226 | 1.7 K to 2.2 K (+27.42 %) |
May 05 2008 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP, Planning and Co ... | Buy | P | 44.35 | 138 | 6,121 | 3,531 | 3.4 K to 3.5 K (+4.07 %) |
May 05 2008 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP, Planning and Co ... | Buy | P | 44.35 | 138 | 6,121 | 3,531 | 3.4 K to 3.5 K (+4.07 %) |
May 05 2008 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | VP, Finance & CFO | Buy | P | 44.35 | 260 | 11,532 | 1,871 | 1.6 K to 1.9 K (+16.14 %) |
May 05 2008 | HAE | HAEMONETICS CORP | Popovsky Mark A | VP, Corporate Medic ... | Buy | P | 44.35 | 246 | 10,911 | 4,891 | 4.6 K to 4.9 K (+5.30 %) |
May 05 2008 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, General Counsel | Buy | P | 44.35 | 328 | 14,548 | 36,422 | 36.1 K to 36.4 K (+0.91 %) |
May 05 2008 | HAE | HAEMONETICS CORP | SWENSON STEPHEN | VP & General Mgr, G ... | Buy | P | 44.35 | 238 | 10,556 | 3,024 | 2.8 K to 3 K (+8.54 %) |
May 05 2008 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Donor Di ... | Buy | P | 44.35 | 297 | 13,173 | 5,266 | 5 K to 5.3 K (+5.98 %) |
May 05 2008 | HAE | HAEMONETICS CORP | Pare Anthony | Buy | P | 44.35 | 231 | 10,246 | 2,523 | 2.3 K to 2.5 K (+10.08 %) | |
Apr 23 2008 | HAE | HAEMONETICS CORP | Pare Anthony | Option Exercise | M | 26.11 | 500 | 13,053 | 4,000 | ||
Apr 23 2008 | HAE | HAEMONETICS CORP | Pare Anthony | Sell | S | 55.98 | 500 | 27,990 | 2,292 | 2.8 K to 2.3 K (-17.91 %) | |
Apr 23 2008 | HAE | HAEMONETICS CORP | Pare Anthony | Buy | M | 26.11 | 500 | 13,053 | 2,792 | 2.3 K to 2.8 K (+21.82 %) | |
Mar 17 2008 | HAE | HAEMONETICS CORP | SWENSON STEPHEN | VP & General Mgr, G ... | Option Exercise | M | 26.11 | 400 | 10,442 | 7,100 | |
Mar 17 2008 | HAE | HAEMONETICS CORP | SWENSON STEPHEN | VP & General Mgr, G ... | Sell | S | 58.87 | 400 | 23,550 | 2,786 | 3.2 K to 2.8 K (-12.55 %) |
Mar 17 2008 | HAE | HAEMONETICS CORP | SWENSON STEPHEN | VP & General Mgr, G ... | Buy | M | 26.11 | 400 | 10,442 | 3,186 | 2.8 K to 3.2 K (+14.36 %) |
Mar 17 2008 | HAE | HAEMONETICS CORP | SWENSON STEPHEN | VP & General Mgr, G ... | Sell | S | 58.43 | 223 | 13,030 | 2,786 | 3 K to 2.8 K (-7.41 %) |
Mar 03 2008 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | VP, General Counsel | Option Exercise | M | 17.63 | 9,500 | 167,438 | 0 |